Next Generation Boswellia Extract
AprèsFLEX® is a new, patent-pending dietary ingredient targeting mediators of comfort and flexibility. These include 5-lipoxygenase, 5-lox activating protein (FLAP), TNF-α and other important mechanisms. By supporting normal, healthy levels of these mediators, AprèsFLEX® promotes healthy joints, connective tissues and respiratory and digestive function. In a recent clinical study, AprèsFLEX® supplementation demonstrated significant improvements in joint comfort, function and mobility. Several objective blood markers of systemic activity were significantly improved as well.
AprèsFLEX® is the next generation boswellia extract. The researchers at Laila Nutra, India, have developed a new composition based upon the clinically-proven Boswellia Serrata extract providing Acetyl-11-keto-ß-boswellic acid (AKBA) with a proprietary Boswellia extract. This unique composition improves the bioavailability and bioactivity of the AKBA while the proprietary extract exhibits 5-LOX inhibition as well. Together, the synergism exceeds the expected benefit of the individual ingredients. AprèsFLEX® also more effectively inhibits MMP-3 activity, helping protect against collagen degradation, an important component of connective tissues*. Tests show that compared to AKBA alone, AprèsFLEX® promotes faster absorption, quicker therapeutic benefit, and the elimination pattern shows longer blood levels suggesting a longer lasting activity.
Developed at the Laila Impex Research Center
AprèsFLEX® is presented in alliance with Laila Impex Research Center, a division of Laila Nutra, a leading producer of herbal extracts and phytochemicals in India. The center is recognized by the Indian Government’s Department of Scientific and Industrial Research (DSIR), is affiliated with numerous university Ph.D. programs, and actively collaborates with a number of US institutions, including Georgetown University and the Ohio State University Medical Center.
AprèsFLEX® supports healthy joints and connective tissues
• AprèsFLEX® is clinically-proven using validated tests of function and blood markers
• AprèsFLEX® helps improve bioavailability and bioactivity of AKBA
• A previously unrecognized synergistic benefit of Boswellia extracts
• AprèsFLEX® also demonstrates significant 5-Lipoxygenase inhibition
• Superior MMP-3 inhibition